MSRM logo

Mushrooms Inc (MSRM)

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Mit einem Kurs von $ ist Mushrooms Inc (MSRM) ein Consumer Defensive-Unternehmen mit einer Bewertung von 0. Die Aktie erzielt 50/100, eine moderate Bewertung basierend auf 9 quantitativen KPIs.

Zuletzt analysiert: 17. März 2026
50/100 KI-Bewertung

Mushrooms Inc (MSRM) Konsumgueeter-Geschaeftsueberblick

CEOKimberly Zawi Carlson
Mitarbeiter6
HauptsitzEstero, US
IPO-Jahr2006

Mushrooms Inc. is a development stage company aiming to consolidate the fragmented mushroom industry through acquisitions and mergers. Formerly focused on marijuana, the company pivoted to mushrooms in 2022. It currently operates with a small team and negative profit margins within the consumer defensive sector.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 17. März 2026

Investmentthese

Mushrooms Inc. presents a high-risk, high-reward investment opportunity centered on its consolidation strategy within the mushroom industry. The company's success depends on its ability to identify and integrate accretive acquisitions, driving revenue growth and achieving economies of scale. Key value drivers include successful execution of the acquisition strategy, expansion into high-margin mushroom products, and effective cost management. However, the company's negative profit margin of -360.0% and gross margin of -19.2% highlight significant financial challenges. Upcoming milestones include identifying and closing initial acquisitions, demonstrating revenue growth, and achieving positive cash flow. The high beta of 2.79 indicates significant volatility. Investors should carefully consider the risks associated with a development-stage company operating in a competitive market.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Market capitalization of $0.00B indicates a micro-cap company with limited resources.
  • P/E ratio of -61.65 reflects negative earnings and challenges in achieving profitability.
  • Profit margin of -360.0% highlights significant operational inefficiencies and cost management issues.
  • Gross margin of -19.2% indicates that the company is currently losing money on each sale.
  • Beta of 2.79 suggests high volatility compared to the overall market.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Strategic focus on the growing mushroom industry.
  • Acquisition-based growth strategy allows for rapid expansion.
  • Potential for diversification into high-margin mushroom products.

Schwaechen

  • Negative profit and gross margins indicate financial instability.
  • Limited operating history as Mushrooms Inc.
  • Small team size may constrain growth potential.

Katalysatoren

  • Upcoming: Potential acquisitions of mushroom companies could drive revenue growth.
  • Upcoming: Expansion into the functional and medicinal mushroom market.
  • Ongoing: Development of value-added mushroom products.
  • Ongoing: Strategic partnerships with retailers and distributors.

Risiken

  • Ongoing: Negative profit and gross margins indicate financial instability.
  • Potential: Competition from established agricultural companies and mushroom farms.
  • Potential: Fluctuations in mushroom prices and demand.
  • Potential: Regulatory changes affecting the mushroom industry.
  • Ongoing: Limited financial disclosure and low liquidity due to OTC listing.

Wachstumschancen

  • Expansion into Functional and Medicinal Mushroom Products: The market for functional and medicinal mushrooms is experiencing rapid growth, driven by increasing consumer interest in natural health and wellness solutions. Mushrooms Inc. can capitalize on this trend by acquiring companies specializing in the production of mushroom-based supplements, extracts, and other health products. The global functional mushroom market is projected to reach $34.3 billion by 2031, offering a substantial growth opportunity for MSRM.
  • Geographic Expansion through Acquisitions: Mushrooms Inc. can expand its geographic reach by acquiring mushroom farms and production facilities in different regions. This would allow the company to diversify its operations, reduce transportation costs, and access new markets. Expansion into regions with favorable growing conditions and strong consumer demand for mushrooms could significantly boost revenue and profitability. This strategy can be implemented within the next 2-3 years.
  • Development of Value-Added Mushroom Products: Mushrooms Inc. can increase its profit margins by developing and marketing value-added mushroom products, such as pre-packaged mushroom meals, marinated mushrooms, and mushroom-based sauces. These products cater to the growing demand for convenient and healthy food options. Investing in product development and marketing could drive significant revenue growth within the next 1-2 years.
  • Strategic Partnerships with Retailers and Distributors: Establishing strategic partnerships with major retailers and distributors can provide Mushrooms Inc. with access to a wider customer base and enhance its brand visibility. Collaborating with supermarkets, health food stores, and online retailers can significantly increase sales volume and market share. These partnerships can be forged within the next year.
  • Implementation of Advanced Farming Technologies: Investing in advanced farming technologies, such as vertical farming and automated harvesting systems, can improve efficiency, reduce labor costs, and increase yields. These technologies can also enable Mushrooms Inc. to produce higher-quality mushrooms with consistent characteristics. Implementing these technologies can lead to long-term cost savings and improved competitiveness within the next 3-5 years.

Chancen

  • Expanding into the functional and medicinal mushroom market.
  • Geographic expansion through strategic acquisitions.
  • Developing value-added mushroom products to increase profit margins.

Risiken

  • Competition from established agricultural companies and mushroom farms.
  • Fluctuations in mushroom prices and demand.
  • Regulatory changes affecting the mushroom industry.

Wettbewerbsvorteile

  • Consolidation strategy: Creating a larger entity through acquisitions may lead to economies of scale.
  • Potential for brand recognition and customer loyalty through consistent quality and product offerings.
  • Access to diverse mushroom varieties and product lines through acquisitions.

Ueber MSRM

Mushrooms Inc., originally founded in 2002 as Marijuana Strategic Ventures Inc., underwent a strategic shift in October 2022, rebranding to reflect its new focus on the mushroom industry. The company's core strategy involves identifying, acquiring, and merging with small, mid-sized, and development-stage companies operating within the mushroom sector. Based in Bonsall, California, Mushrooms Inc. aims to capitalize on the growing interest in functional and medicinal mushrooms, as well as the broader culinary market. The company's evolution from marijuana to mushrooms reflects a strategic adaptation to changing market dynamics and regulatory landscapes. By consolidating various players in the mushroom industry, Mushrooms Inc. seeks to create economies of scale, enhance operational efficiencies, and expand its product offerings. Currently, the company is in the early stages of executing its acquisition-based growth strategy. Its small team of six employees manages the complexities of identifying suitable acquisition targets and integrating them into a cohesive business operation. While the company's strategic vision is clear, its financial performance indicates the challenges inherent in its current development stage. With negative profit and gross margins, Mushrooms Inc. needs to demonstrate its ability to generate revenue and achieve profitability through successful acquisitions and operational improvements. The company's future success hinges on its ability to effectively execute its consolidation strategy and capitalize on the growth potential of the mushroom industry.

Was das Unternehmen tut

  • Acquire small to mid-sized companies in the mushroom industry.
  • Merge acquired companies to create a larger, more efficient entity.
  • Focus on companies in the development stage within the mushroom sector.
  • Produce and distribute various types of mushrooms.
  • Potentially develop and market value-added mushroom products.
  • Explore opportunities in the functional and medicinal mushroom market.

Geschaeftsmodell

  • Acquisition-based growth strategy: Acquire and merge with existing mushroom companies.
  • Revenue generation through sales of mushrooms and related products.
  • Potential for revenue diversification through value-added products and strategic partnerships.

Branchenkontext

Mushrooms Inc. operates within the agricultural farm products industry, a segment of the broader consumer defensive sector. The mushroom market is experiencing growth driven by increasing consumer awareness of the health benefits of functional and medicinal mushrooms, as well as the continued popularity of culinary mushrooms. The competitive landscape includes established agricultural companies, smaller mushroom farms, and specialized producers of mushroom-derived products. Competitors include AAGR (Advanced Agrilytics), ASII (Atlas Corp), DKAM (DeKang Agriculture), EARI (Eastern Resources Inc), and HERF (China Green Agriculture). Mushrooms Inc. aims to differentiate itself through its acquisition-based consolidation strategy, seeking to create a larger, more efficient, and diversified mushroom company.

Wichtige Kunden

  • Retail consumers purchasing mushrooms for culinary use.
  • Restaurants and food service providers using mushrooms in their dishes.
  • Manufacturers of functional and medicinal mushroom products.
  • Potential partnerships with retailers and distributors.
KI-Zuversicht: 69% Aktualisiert: 17. März 2026

Finanzdaten

Chart & Info

Mushrooms Inc (MSRM) Aktienkurs: Price data unavailable

Aktuelle Nachrichten

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer MSRM.

Kursziele

Wall-Street-Kurszielanalyse fuer MSRM.

MoonshotScore

50/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von MSRM auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Fuehrung: Kimberly Zawi Carlson

CEO

Kimberly Zawi Carlson serves as the CEO of Mushrooms Inc., leading a team of six employees. Information regarding Ms. Carlson's detailed career history, education, and previous roles is not available. As CEO, she is responsible for guiding the company's strategic direction, overseeing its acquisition-based growth strategy, and managing its day-to-day operations. Her leadership is crucial for navigating the challenges of a development-stage company in a competitive market.

Erfolgsbilanz: Due to limited information available, it is difficult to assess Kimberly Zawi Carlson's track record. The company's recent shift in focus to the mushroom industry and its current financial performance provide limited data points for evaluating her leadership. Key milestones to watch include the successful completion of acquisitions, revenue growth, and improvements in profitability under her guidance.

MSRM OTC-Marktinformationen

The OTC Other tier represents the lowest tier of the OTC market, indicating that Mushrooms Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the potential for limited information and increased volatility.

  • OTC-Stufe: OTC Other
  • Offenlegungsstatus: Unknown
Liquiditaet: Liquidity in OTC Other stocks is typically very low, with wide bid-ask spreads and limited trading volume. This can make it difficult for investors to buy or sell shares without significantly impacting the price. The low liquidity also increases the risk of price manipulation and makes it challenging to establish a fair market value for the stock. Investors should exercise extreme caution when trading MSRM due to the potential for illiquidity.
OTC-Risikofaktoren:
  • Limited financial disclosure increases the risk of investing in MSRM.
  • Low liquidity can make it difficult to buy or sell shares at desired prices.
  • Increased potential for price manipulation due to low trading volume.
  • Lack of regulatory oversight compared to major exchanges.
  • Higher volatility and potential for significant price swings.
Sorgfaltspruefung-Checkliste:
  • Verify the company's financial statements and disclosures.
  • Assess the company's business model and competitive landscape.
  • Evaluate the management team's experience and track record.
  • Understand the risks associated with investing in OTC Other stocks.
  • Monitor trading volume and bid-ask spreads to assess liquidity.
  • Consult with a financial advisor before investing.
  • Research the company's history and any potential red flags.
Legitimitaetssignale:
  • Company's stated focus on acquiring and merging with mushroom companies.
  • Change of name to reflect the shift in business focus.
  • Existence of a CEO and a small team of employees.

Was Anleger ueber Mushrooms Inc (MSRM) wissen wollen

What are the key factors to evaluate for MSRM?

Mushrooms Inc (MSRM) currently holds an AI score of 50/100, indicating moderate score. Key strength: Strategic focus on the growing mushroom industry.. Primary risk to monitor: Ongoing: Negative profit and gross margins indicate financial instability.. This is not financial advice.

How frequently does MSRM data refresh on this page?

MSRM prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven MSRM's recent stock price performance?

Recent price movement in Mushrooms Inc (MSRM) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Strategic focus on the growing mushroom industry.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider MSRM overvalued or undervalued right now?

Determining whether Mushrooms Inc (MSRM) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying MSRM?

Before investing in Mushrooms Inc (MSRM), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding MSRM to a portfolio?

Potential reasons to consider Mushrooms Inc (MSRM) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Strategic focus on the growing mushroom industry.. Additionally: Acquisition-based growth strategy allows for rapid expansion.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of MSRM?

Yes, most major brokerages offer fractional shares of Mushrooms Inc (MSRM) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track MSRM's earnings and financial reports?

Mushrooms Inc (MSRM) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for MSRM earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Limited information available on the company's operations and financial performance.
  • OTC listing increases investment risk due to limited disclosure and liquidity.
Datenquellen

Popular Stocks